141 related articles for article (PubMed ID: 14634714)
1. Abuse liability and stimulant properties of dextromethorphan and diphenhydramine combinations in rats.
Jun JH; Thorndike EB; Schindler CW
Psychopharmacology (Berl); 2004 Mar; 172(3):277-82. PubMed ID: 14634714
[TBL] [Abstract][Full Text] [Related]
2. The stimulus properties of two common over-the-counter drug mixtures: dextromethorphan + ephedrine and dextromethorphan + diphenhydramine.
Gauvin DV; Vanecek SA; Baird TJ; Vallett M; Briscoe RJ; Carl KL; Holloway FA; Sannerud CA
J Psychopharmacol; 1998; 12(1):84-92. PubMed ID: 9584972
[TBL] [Abstract][Full Text] [Related]
3. Dextromethorphan alters the reinforcing effect of cocaine in the rat.
Kim HC; Park BK; Hong SY; Jhoo WK
Methods Find Exp Clin Pharmacol; 1997 Nov; 19(9):627-31. PubMed ID: 9500126
[TBL] [Abstract][Full Text] [Related]
4. Dextromethorphan affects ventilation differently in male and female rats.
Schlenker EH
J Appl Physiol (1985); 1996 Nov; 81(5):1911-6. PubMed ID: 8941509
[TBL] [Abstract][Full Text] [Related]
5. Methylphenidate enhances the abuse-related behavioral effects of nicotine in rats: intravenous self-administration, drug discrimination, and locomotor cross-sensitization.
Wooters TE; Neugebauer NM; Rush CR; Bardo MT
Neuropsychopharmacology; 2008 Apr; 33(5):1137-48. PubMed ID: 17581534
[TBL] [Abstract][Full Text] [Related]
6. Antitussive activity of sigma-1 receptor agonists in the guinea-pig.
Brown C; Fezoui M; Selig WM; Schwartz CE; Ellis JL
Br J Pharmacol; 2004 Jan; 141(2):233-40. PubMed ID: 14691051
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cough reflex sensitivity by diphenhydramine during acute viral respiratory tract infection.
Dicpinigaitis PV; Dhar S; Johnson A; Gayle Y; Brew J; Caparros-Wanderley W
Int J Clin Pharm; 2015 Jun; 37(3):471-4. PubMed ID: 25673148
[TBL] [Abstract][Full Text] [Related]
8. Low doses of dextromethorphan attenuate morphine-induced rewarding via the sigma-1 receptor at ventral tegmental area in rats.
Chen SL; Hsu KY; Huang EY; Lu RB; Tao PL
Drug Alcohol Depend; 2011 Sep; 117(2-3):164-9. PubMed ID: 21320758
[TBL] [Abstract][Full Text] [Related]
9. Preparation and in vitro release of dual-drug resinates containing equivalent content dextromethorphan and diphenhydramine.
Akkaramongkolporn P; Kulvanich P; Pathipvanich M
Drug Dev Ind Pharm; 2006 Apr; 32(4):483-96. PubMed ID: 16638687
[TBL] [Abstract][Full Text] [Related]
10. Dextromethorphan interactions with histaminergic and serotonergic treatments to reduce nicotine self-administration in rats.
Briggs SA; Hall BJ; Wells C; Slade S; Jaskowski P; Morrison M; Rezvani AH; Rose JE; Levin ED
Pharmacol Biochem Behav; 2016 Mar; 142():1-7. PubMed ID: 26704812
[TBL] [Abstract][Full Text] [Related]
11. Self-administration of cocaine-antihistamine combinations: super-additive reinforcing effects.
Wang Z; Woolverton WL
Eur J Pharmacol; 2007 Feb; 557(2-3):159-60. PubMed ID: 17196194
[TBL] [Abstract][Full Text] [Related]
12. Codeine consumption from over-the-counter anti-cough syrup in Taiwan: A useful indicator for opioid abuse.
Lo MY; Ong MW; Lin JG; Sun WZ
Acta Anaesthesiol Taiwan; 2015 Dec; 53(4):135-8. PubMed ID: 26646544
[TBL] [Abstract][Full Text] [Related]
13. Abuse liability assessment in preclinical drug development: predictivity of a translational approach for abuse liability testing using methylphenidate in four standardized preclinical study models.
Teuns GB; Geys HM; Geuens SM; Stinissen P; Meert TF
J Pharmacol Toxicol Methods; 2014; 70(3):295-309. PubMed ID: 24632211
[TBL] [Abstract][Full Text] [Related]
14. Mutually augmenting interactions of dextromethorphan and sazetidine-A for reducing nicotine self-administration in rats.
Levin ED; Wells C; Slade S; Rezvani AH
Pharmacol Biochem Behav; 2018 Mar; 166():42-47. PubMed ID: 29407477
[TBL] [Abstract][Full Text] [Related]
15. Dextromethorphan reduces intravenous cocaine self-administration in the rat.
Pulvirenti L; Balducci C; Koob GF
Eur J Pharmacol; 1997 Mar; 321(3):279-83. PubMed ID: 9085038
[TBL] [Abstract][Full Text] [Related]
16. Locomotor stimulant effects of intraventricular injections of low doses of ethanol in rats: acute and repeated administration.
Correa M; Arizzi MN; Betz A; Mingote S; Salamone JD
Psychopharmacology (Berl); 2003 Dec; 170(4):368-75. PubMed ID: 12955297
[TBL] [Abstract][Full Text] [Related]
17. Oral administration of dextromethorphan does not produce neuronal vacuolation in the rat brain.
Carliss RD; Radovsky A; Chengelis CP; O'Neill TP; Shuey DL
Neurotoxicology; 2007 Jul; 28(4):813-8. PubMed ID: 17573115
[TBL] [Abstract][Full Text] [Related]
18. Effects of dextromethorphan on nocturnal behavior and brain c-Fos expression in adolescent rats.
Jahng JW; Zhang TY; Lee S; Kim DG
Eur J Pharmacol; 2001 Nov; 431(1):47-52. PubMed ID: 11716842
[TBL] [Abstract][Full Text] [Related]
19. Discriminative stimulus properties of dextromethorphan in rats.
Gavend M; Mallaret M; Dematteis M; Baragatti G
Biomed Pharmacother; 1995; 49(10):456-64. PubMed ID: 8746072
[TBL] [Abstract][Full Text] [Related]
20. The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats.
Solinas M; Panlilio LV; Antoniou K; Pappas LA; Goldberg SR
J Pharmacol Exp Ther; 2003 Jul; 306(1):93-102. PubMed ID: 12660305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
